CGONCG Oncology, Inc. Common stock

CGON Stock Price, Valuation & Chart | CG Oncology, Inc. Common stock

Compare

$74.590-1.27 (-1.67%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology CGON intrinsic value CGON calculated fair value vs price

Overview Financials Dividends Ratios

CGON Historical price chart

CGON Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization6.58B

PE Ratio-27.73

EPS-2.69

Trading Volume663.82K

Today's High/Low79.23/73.89

Dividend Yield0.00

52 Week High/Low80.97/26.91

Shares Outstanding88.20M

CGON Financial Statement

CGON Analyst ratings

CGON Analysis & performance metrics

CGON Company profile

CG Oncology Inc is a clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with…

CG Oncology Inc is a clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. Their product candidate cretostimogene, is initially in clinical development for the treatment of patients with high-risk Non-Muscle Invasive Bladder Cancer who are unresponsive to Bacillus Calmette…

CGON Management team

Name

Position

Sarah Connors

Vice President of Communications & Patient Advocacy

Corleen M. RocheCFO

Chief Financial Officer

Vijay Kasturi M.D.

Chief Medical Officer

Joshua F. Patterson

General Counsel, Chief Compliance Officer & Secretary

Swapnil Bhargava Ph.D.

Chief Technical Officer

Arthur KuanCEO

Chairman & Chief Executive Officer

Ambaw Bellete M.S.COO

President & Chief Operating Officer

Amy Steele

Vice President of Finance, Accounting & Administration

Name

Position

Sarah Connors

Vice President of Communications & Patient Advocacy

Corleen M. RocheCFO

Chief Financial Officer

Vijay Kasturi M.D.

Chief Medical Officer

Joshua F. Patterson

General Counsel, Chief Compliance Officer & Secretary

Swapnil Bhargava Ph.D.

Chief Technical Officer

Arthur KuanCEO

Chairman & Chief Executive Officer

Ambaw Bellete M.S.COO

President & Chief Operating Officer

Amy Steele

Vice President of Finance, Accounting & Administration

Management Team

Sarah Connors

Vice President of Communications & Patient Advocacy

Corleen M. RocheCFO

Chief Financial Officer

Vijay Kasturi M.D.

Chief Medical Officer

Joshua F. Patterson

General Counsel, Chief Compliance Officer & Secretary

Swapnil Bhargava Ph.D.

Chief Technical Officer

Arthur KuanCEO

Chairman & Chief Executive Officer

Ambaw Bellete M.S.COO

President & Chief Operating Officer

Amy Steele

Vice President of Finance, Accounting & Administration

Management

Sarah Connors

Vice President of Communications & Patient Advocacy

Corleen M. RocheCFO

Chief Financial Officer

Vijay Kasturi M.D.

Chief Medical Officer

Joshua F. Patterson

General Counsel, Chief Compliance Officer & Secretary

Swapnil Bhargava Ph.D.

Chief Technical Officer

Arthur KuanCEO

Chairman & Chief Executive Officer

Ambaw Bellete M.S.COO

President & Chief Operating Officer

Amy Steele

Vice President of Finance, Accounting & Administration

Total 8 executives

CGON Frequently asked questions

What is CG Oncology, Inc. Common stock (CGON) Stock Price?

Current stock price of CG Oncology, Inc. Common stock (CGON) stock is $74.590. The stock price is -1.67% lower in the session. The intraday range can be seen from this page. Volume of CG Oncology, Inc. Common stock (CGON) stock is 663.82K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the CG Oncology, Inc. Common stock (CGON) stock price going up or down today?

The stock price of CG Oncology, Inc. Common stock (CGON) can change with earnings, company news, and overall market sentiment. CG Oncology, Inc. Common stock operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the CG Oncology, Inc. Common stock stock expensive at its current price?

Whether CG Oncology, Inc. Common stock looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for CGON on this page is -27.73. EPS on this page is -2.69. Compare those figures with peers and growth expectations before deciding if the current CG Oncology, Inc. Common stock price is justified.

How has the stock price of CG Oncology, Inc. Common stock (CGON) performed historically?

Historical performance for CG Oncology, Inc. Common stock (CGON) is shown on the price chart on this page. Review multi-period moves alongside volume to see how CGON reacted to past earnings and market events.

Should I buy CG Oncology, Inc. Common stock (CGON) stock, at this price?

Buying CG Oncology, Inc. Common stock (CGON) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.